Theodore A. Omachi

4.5k total citations · 1 hit paper
57 papers, 3.0k citations indexed

About

Theodore A. Omachi is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Theodore A. Omachi has authored 57 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Physiology, 25 papers in Pulmonary and Respiratory Medicine and 13 papers in Immunology and Allergy. Recurrent topics in Theodore A. Omachi's work include Asthma and respiratory diseases (28 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers) and Allergic Rhinitis and Sensitization (13 papers). Theodore A. Omachi is often cited by papers focused on Asthma and respiratory diseases (28 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers) and Allergic Rhinitis and Sensitization (13 papers). Theodore A. Omachi collaborates with scholars based in United States, Switzerland and United Kingdom. Theodore A. Omachi's co-authors include Paul D. Blanc, Mark D. Eisner, Patricia Katz, Carlos Iribarren, Edward H. Yelin, Ed Yelin, Benjamin Trzaskoma, Ryan Owen, Karin Rosén and Lynn Ackerson and has published in prestigious journals such as American Journal of Epidemiology, American Journal of Public Health and CHEST Journal.

In The Last Decade

Theodore A. Omachi

55 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

2020 453 citations Philippe Gevaert, Theodore A. Omachi et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Theodore A. Omachi United States	24	1.4k	1.4k	799	427	392	57	3.0k
J Mark FitzGerald Canada	22	1.0k 0.7×	1.4k 1.0×	377 0.5×	46 0.1×	149 0.4×	46	2.3k
Priti Jhingran United States	19	1.1k 0.8×	1.6k 1.1×	223 0.3×	40 0.1×	192 0.5×	30	2.7k
E. F. Juniper Canada	18	1.7k 1.2×	2.2k 1.6×	704 0.9×	30 0.1×	221 0.6×	32	3.3k
N. Khaltaev Switzerland	13	650 0.5×	947 0.7×	549 0.7×	39 0.1×	89 0.2×	25	1.8k
Randall W. Brown United States	23	640 0.5×	872 0.6×	135 0.2×	72 0.2×	486 1.2×	60	1.7k
Ed Yelin United States	26	550 0.4×	252 0.2×	60 0.1×	25 0.1×	398 1.0×	50	2.6k
Laurent Laforest France	24	681 0.5×	798 0.6×	191 0.2×	17 0.0×	118 0.3×	77	1.5k
Gary Globe United States	24	438 0.3×	550 0.4×	86 0.1×	20 0.0×	169 0.4×	56	1.8k
Catherine J. Hill Australia	30	2.7k 1.9×	712 0.5×	17 0.0×	16 0.0×	248 0.6×	71	4.4k
Paschalis Steiropoulos Greece	28	1.4k 1.0×	1.6k 1.1×	41 0.1×	6 0.0×	107 0.3×	203	3.1k

Countries citing papers authored by Theodore A. Omachi

Since Specialization

Citations

This map shows the geographic impact of Theodore A. Omachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore A. Omachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore A. Omachi more than expected).

Fields of papers citing papers by Theodore A. Omachi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore A. Omachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore A. Omachi. The network helps show where Theodore A. Omachi may publish in the future.

Co-authorship network of co-authors of Theodore A. Omachi

This figure shows the co-authorship network connecting the top 25 collaborators of Theodore A. Omachi. A scholar is included among the top collaborators of Theodore A. Omachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodore A. Omachi. Theodore A. Omachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rovin, Brad H., Valeria Albertón, Jay Garg, et al.. (2025). Beyond Clinical Response in the REGENCY Trial: The Impact of Obinutuzumab on Histologic Remission in Patients with Active Lupus Nephritis. Journal of the American Society of Nephrology. 36(10S).

Rovin, Brad H., Richard Furie, Jay Garg, et al.. (2025). WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS. Kidney International Reports. 10(2). S771–S772. 1 indexed citations

Zhu, Rui, Rik C. Schoemaker, Xianbin Tian, et al.. (2024). Model‐based comparisons of post‐treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European Union. British Journal of Clinical Pharmacology. 90(12). 3190–3200. 1 indexed citations

Spain, C. Victor, et al.. (2021). Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma. Journal of Asthma. 59(6). 1237–1247. 7 indexed citations

Zhu, Rui, Ryan Owen, Justin Wilkins, et al.. (2021). Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polyps. Pulmonary Pharmacology & Therapeutics. 71. 102080–102080. 2 indexed citations

Gevaert, Philippe, Peter W. Hellings, J. Mullol, et al.. (2020). Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis. Allergy. 75. 108–108. 1 indexed citations

Corren, Jonathan, Claus Bachert, Philippe Gevaert, et al.. (2020). Omalizumab Improves Quality of Life in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma. Journal of Allergy and Clinical Immunology. 145(2). AB250–AB250. 3 indexed citations

Gevaert, Philippe, Theodore A. Omachi, Jonathan Corren, et al.. (2020). Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. Journal of Allergy and Clinical Immunology. 146(3). 595–605. 453 indexed citations breakdown →

Casale, Thomas B., Bradley E. Chipps, Karin Rosén, et al.. (2017). Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma. Allergy. 73(2). 490–497. 104 indexed citations

10.

Antonova, Evgeniya, Benjamin Trzaskoma, Theodore A. Omachi, & Michael Schätz. (2016). Poor Asthma Control Is Associated with Overall Daily Activity Impairment: 3-Year Data from the EXCELS Study of Omalizumab. Journal of Allergy and Clinical Immunology. 137(2). AB14–AB14. 4 indexed citations

11.

Ledford, Dennis K., William W. Busse, Benjamin Trzaskoma, et al.. (2016). A randomized multicenter study evaluating Xolair persistence of response after long-term therapy. Journal of Allergy and Clinical Immunology. 140(1). 162–169.e2. 146 indexed citations

12.

Iribarren, Carlos, Abdelkader Rahmaoui, Aidan A. Long, et al.. (2016). Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma. Journal of Allergy and Clinical Immunology. 139(5). 1489–1495.e5. 80 indexed citations

13.

Busse, William W., Theodore A. Omachi, Janice Canvin, et al.. (2014). Evaluating omalizumab persistency of response after long-term therapy (XPORT). European Respiratory Journal. 44(Suppl 58). P3485–P3485. 9 indexed citations

14.

Singer, Jonathan P., Patricia Katz, Carlos Iribarren, et al.. (2012). Both Pulmonary and Extra-Pulmonary Factors Predict the Development of Disability in Chronic Obstructive Pulmonary Disease. Respiration. 85(5). 375–383. 10 indexed citations

15.

Omachi, Theodore A., Urmimala Sarkar, Edward H. Yelin, Paul D. Blanc, & Patricia Katz. (2012). Lower Health Literacy is Associated with Poorer Health Status and Outcomes in Chronic Obstructive Pulmonary Disease. Journal of General Internal Medicine. 28(1). 74–81. 141 indexed citations

16.

Katz, Patricia, Hubert Chen, Theodore A. Omachi, et al.. (2011). The Role of Physical Inactivity in Increasing Disability Among Older Adults With Obstructive Airway Disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 31(3). 193–197. 16 indexed citations

17.

Katz, Patricia, Anne Morris, Laura Julián, et al.. (2010). Onset of depressive symptoms among adults with asthma: results from a longitudinal observational cohort. Primary Care Respiratory Journal. 19(3). 223–230. 16 indexed citations

18.

Omachi, Theodore A., Patricia Katz, Edward H. Yelin, et al.. (2009). Depression and Health-Related Quality of Life in Chronic Obstructive Pulmonary Disease. The American Journal of Medicine. 122(8). 778.e9–778.e15. 105 indexed citations

19.

Eisner, Mark D., Carlos Iribarren, Ed Yelin, et al.. (2008). Pulmonary Function and the Risk of Functional Limitation in Chronic Obstructive Pulmonary Disease. American Journal of Epidemiology. 167(9). 1090–1101. 72 indexed citations

20.

Sarkar, Urmimala, et al.. (2007). SynopSIS: Integrating physician sign‐out with the electronic medical record. Journal of Hospital Medicine. 2(5). 336–342. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact